<DOC>
	<DOCNO>NCT01041495</DOCNO>
	<brief_summary>Amrix ( Cyclobenzaprine hydrochloride Extended release capsule ) approve FDA muscle relaxant , indicate treatment muscle spasm associate acute , painful musculoskeletal condition . Cyclobenzaprine ER ( Amrix TM ) distinct pharmacokinetic profile provide early systemic exposure consistent plasma concentration several hour . Overall , single dose Amrix 30 mg similar cyclobenzaprine immediate release 10 mg three time daily . This ER formula improve compliance , similar efficacy possibly less side effect often case slow release formulation . There clinical study show cyclobenzaprine alleviate pain secondary Fibromyalgia induce muscle tone . This multi-layered evidence base suggest cyclobenzaprine may able alleviate pain fibromyalgia . Theoretically fibromyalgia , pain interpret centrally possibly occur due say muscle spasm . Cyclobenzaprine may relieve pain , thus allow patient function good day sleep good night . Cyclobenzaprine tricyclic antidepressant structure may also allow pain signal dampening spinal cord well , similar amitriptyline use off-label neuropathic pain well . Fibromyalgia ( FM ) illness may involve medical , rheumatologic , autoimmune , sleep , endocrine psychiatric pathology . It syndrome recurrent pain trigger point . Greater 90 % patient report fatigue key symptom well . There several investigation line treatment FM induce pain . Exercise , behavioral therapy , amitryptiline , duloxetine , tramadol , sodium oxybate , pregabalin randomize trial almost focus pain . There study evaluate cyclobenzaprine none study Cyclobenzaprine ER formulation . None evaluate pain reduction , sleep fatigue improvement . Cyclobenzaprine drug minimal adverse effect ( dry mouth , dizziness , fatigue , constipation , somnolence , nausea , dyspepsia ) . It may safer tolerability profile FM medication note . As cyclobenzaprine often study often added augmentation agent patient ' regimen suffer acute painful musculoskeletal condition , author feel cyclobenzaprine would also effective population . The author wish conduct study determine cyclobenzaprine ER safe tolerable treatment FM induce pain , secondary fatigue insomnia . This initial study may allow continue regulatory study product FM subject . The author propose double-blind placebo control study determine cyclobenzaprine ER safe effective reverse FM induce pain , secondary fatigue insomnia .</brief_summary>
	<brief_title>Cyclobenzaprine Extended Release ( ER ) Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Cyclobenzaprine</mesh_term>
	<mesh_term>Amitriptyline</mesh_term>
	<criteria>If possible , 60 subject include study . All males/females race eligible age 18 65 Subjects must speak English capacity receive utilize inform consent Agree use barrier method contraception infertile x 2 year due medical condition surgery Have formally diagnose Board Certified Rheumatologist use ACR 1990 research criterion fibromyalgia Report pain key distress symptom FM Have score &gt; 4 Visual Analogue Pain Scale ( VAPS ) Subjects Be pregnant attempt conceive present ( urine bHCG must negative ) Have active substance abuse problem last use within past 90 day ( outside nicotine ) Use cardiac QTc prolonging medication i.e. , tricyclic antidepressant Use p4502D6 major inhibit medication cyclobenzaprine level may increase Have know medical condition outside FM cause pain , i.e. , diabetic neuropathy Have know medical condition medication use relatively contraindicate cyclobenzaprine use ( i.e. , hypersensitivity concomitant use monoamine oxidase ( MAO ) inhibitor , seizure , know cardiac abnormality , recent MI . hepatitis , stroke , psychosis Has prior history cyclobenzaprine use failure ( failure due side effect may allow P.I . discretion ) Be receive daytime/nighttime sedate medication clear chronological impact fatigue UNLESS fatigue predate sedate medication say medication steadily dose &gt; 4 week Other medication know alleviate pain ( i.e. , Gabapentin , Pregabalin , Amitryptiline , Duloxetine , Venlafaxine , Carbamazepine , Tramadol , etc ) unless steady dose 6 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>fibromyalgia</keyword>
	<keyword>Pain</keyword>
	<keyword>Sleep</keyword>
	<keyword>Fatigue</keyword>
</DOC>